Clayton Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-449
Closed -$110K 337
2026
Q1
$110K Hold
449
0.06% 99
2025
Q4
$92.9K Buy
449
+299
+199% +$59.1K 0.05% 110
2025
Q3
$27.8K Buy
+150
New +$25.7K 0.02% 108
2025
Q2
Sell
-5,264
Closed -$873K 72
2025
Q1
$873K Sell
5,264
-933
-15% -$146K 0.32% 48
2024
Q4
$896K Sell
6,197
-87
-1% -$13.5K 0.32% 47
2024
Q3
$1.02M Buy
6,284
+840
+15% +$134K 0.38% 44
2024
Q2
$861K Hold
5,444
0.37% 45
2024
Q1
$861K Buy
+5,444
New +$867K 0.39% 45

Other funds holding JNJ

Clayton Financial Group's JNJ Position: Q2 2026 in Review

Clayton Financial Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 449 shares — an estimated $110K sold.

Clayton Financial Group first reported a position in JNJ in Q1 2024 and held it in 8 quarters. The position peaked at $1.02M in Q3 2024. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clayton Financial Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 449 Johnson & Johnson shares in Q2 2026, an estimated $110K.
  • Clayton Financial Group first reported a position in Johnson & Johnson in Q1 2024 and held it in 8 quarters.
  • Clayton Financial Group's Johnson & Johnson position peaked at $1.02M in Q3 2024.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.